Evaluation of MRI Radiomic Features as Surrogates of Tumor Immune Status in Breast Cancer: A Pilot Study of MRI-Derived Radiomic Features for Non-Invasive Immune Profiling in Breast Cancer.

backgroundTumor-infiltrating lymphocytes (TILs) and CD8+ T cell density are important predictors of immunotherapy response in breast cancer, but their evaluation requires invasive tissue biopsies. Radiomics, which enables high-throughput extraction of quantitative imaging features, offers a promising non-invasive approach to characterize the tumor immune microenvironment (TIME). This study evaluates whether MRI-derived radiomic features could predict immune infiltration status in breast cancer. Additionally, we have developed an on-line browser-based tool that can predict the immune status of the tumor environment.

methodsPreoperative MRI and matched transcriptomic data from 38 breast cancer patients were obtained from TCIA and TCGA-BRCA datasets. Tumors were manually segmented using 3D Slicer, and radiomic features were extracted using PyRadiomics. Eighteen biologically relevant radiomic features associated with immune status were selected for modeling. Immune markers included CD8B gene expression, CD8+ T cell infiltration estimated by CIBERSORT, and Immune Score estimated by ESTIMATE. Machine learning models, including Random Forest, Support Vector Machine, Deep Learning, and Elastic Net, were trained to classify immune-high versus immune-low tumors, followed by validation in an independent cohort of 13 patients.

resultsRandom Forest demonstrated strong internal performance (AUCs of 0.945, 0.993, and 0.974 for CD8B expression, CD8+ T cell infiltration, and Immune Score, respectively), but this dropped substantially in the held-out test partition and in an independent external validation cohort (

conclusionsThese findings provide proof-of-concept that MRI-based radiomic features may serve as potential non-invasive biomarkers of the breast tumor immune microenvironment, pending validation in larger, independent cohorts.